http://www.raredr.com/conferences/nord-breakthrough-summit-2015/genzymes-mission
Genzyme's Mission: Diagnose Rare Disease Patients Earlier

Richard Peters, MD, PhD




A key factor in better managing patients with rare diseases is to diagnose the condition as quickly as possible. One survey conducted a few years ago showed that the average time from first symptoms to proper diagnosis of a rare disease was 4-7 years.

At the NORD Breakthough Summit held in Arlington Virgina, we talked with Richard Peters, MD, PhD, head of the global rare disease business unit at Genzyme about some of the programs Genzyme is involved with to diagnose patients with rare diseases more easily.
Printer Printing...
$content$